Nurix Therapeutics, Inc. NRIX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$295.28M-41.7% | -$264.46M-36.6% | -$244.79M-38.3% | -$207.32M-25.6% | -$208.4M-44.0% | ||
| $8.59M-10.8% | $8.74M-6.2% | $9.17M+5.4% | $9.54M+15.4% | $9.62M+23.0% | ||
| $38.65M+11.0% | $37.97M+11.9% | $37.39M+11.8% | $36.37M+9.8% | $34.83M+5.5% | ||
| -$260.29M-35.8% | -$249.47M-44.5% | -$230.38M— | -$215.18M— | -$191.72M— | ||
| $11.56M+17.1% | $14M+51.0% | $10.98M+12.5% | $10.61M+7.6% | $9.87M+9.6% | ||
| -$1.51M+99.4% | $147.85M+157% | $6.69M— | -$65.12M— | -$267.69M— | ||
| $257.14M-47.0% | $238.64M-50.9% | $203.16M-28.8% | $247.77M+2.8% | $485.52M+14,350% | ||
| -$4.65M— | $137.03M— | -$20.54M— | —— | —— | ||
| -$271.85M-34.9% | -$263.47M-44.9% | -$241.36M— | -$225.79M— | -$201.59M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nurix Therapeutics, Inc. generate?
- Nurix Therapeutics, Inc. (NRIX) generated -$260.3M in operating cash flow over the trailing twelve months.
- What is Nurix Therapeutics, Inc.'s free cash flow?
- After $11.6M of capital expenditures, Nurix Therapeutics, Inc.'s free cash flow was -$271.9M over the trailing twelve months, down 34.8% year over year.
- Where does Nurix Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Nurix Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
